Alfred L. Garfall, MD, opens a discussion underscoring the unmet needs in multiple myeloma.
ASCO 2024: Updates in Multiple Myeloma
Dr Garfall, MD, provides insights following results derived from the MajesTEC-1 study.
Dr Garfall, MD, provides further insights around the MajesTEC-1 study.
Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Culturally Competent Menopause Care: Lisa Taylor-Swanson, PhD
3
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
4
Age-Related Disparities in ADC Treatment Rates in Breast Cancer with Tabby Khan, MD
5
